Literature DB >> 16372060

Pharmacogenetics of epilepsy: one step forward?

Graeme J Sills.   

Abstract

Entities:  

Year:  2005        PMID： 16372060      PMCID： PMC1312742          DOI： 10.1111/j.1535-7511.2005.00074.x

Source DB:  PubMed          Journal:  Epilepsy Curr        ISSN： 1535-7511            Impact factor:   7.500


× No keyword cloud information.
  11 in total

Review 1.  Single nucleotide polymorphisms as tools in human genetics.

Authors:  I C Gray; D A Campbell; N K Spurr
Journal:  Hum Mol Genet       Date:  2000-10       Impact factor: 6.150

2.  Roles of cytochrome P4502C9 and cytochrome P4502C19 in the stereoselective metabolism of phenytoin to its major metabolite.

Authors:  M Bajpai; L K Roskos; D D Shen; R H Levy
Journal:  Drug Metab Dispos       Date:  1996-12       Impact factor: 3.922

3.  Association of multidrug resistance in epilepsy with a polymorphism in the drug-transporter gene ABCB1.

Authors:  Asra Siddiqui; Reinhold Kerb; Michael E Weale; Ulrich Brinkmann; Alice Smith; David B Goldstein; Nicholas W Wood; Sanjay M Sisodiya
Journal:  N Engl J Med       Date:  2003-04-10       Impact factor: 91.245

4.  Failure to replicate previously reported genetic associations with sporadic temporal lobe epilepsy: where to from here?

Authors:  Gianpiero L Cavalleri; John M Lynch; Chantal Depondt; Mari-Wyn Burley; Nicholas W Wood; Sanjay M Sisodiya; David B Goldstein
Journal:  Brain       Date:  2005-05-11       Impact factor: 13.501

5.  Genetic predictors of the maximum doses patients receive during clinical use of the anti-epileptic drugs carbamazepine and phenytoin.

Authors:  Sarah K Tate; Chantal Depondt; Sanjay M Sisodiya; Gianpiero L Cavalleri; Stephanie Schorge; Nicole Soranzo; Maria Thom; Arjune Sen; Simon D Shorvon; Josemir W Sander; Nicholas W Wood; David B Goldstein
Journal:  Proc Natl Acad Sci U S A       Date:  2005-04-01       Impact factor: 11.205

6.  Pharmacological outcomes in newly diagnosed epilepsy.

Authors:  Rajiv Mohanraj; Martin J Brodie
Journal:  Epilepsy Behav       Date:  2005-05       Impact factor: 2.937

7.  A common genetic basis for idiosyncratic toxicity of warfarin and phenytoin.

Authors:  A E Rettie; R L Haining; M Bajpai; R H Levy
Journal:  Epilepsy Res       Date:  1999-07       Impact factor: 3.045

Review 8.  Pharmacogenetics.

Authors:  A D Roses
Journal:  Hum Mol Genet       Date:  2001-10-01       Impact factor: 6.150

9.  Lack of association between the C3435T polymorphism in the human multidrug resistance (MDR1) gene and response to antiepileptic drug treatment.

Authors:  Graeme J Sills; Rajiv Mohanraj; Elaine Butler; Sheila McCrindle; Lindsay Collier; Elaine A Wilson; Martin J Brodie
Journal:  Epilepsia       Date:  2005-05       Impact factor: 5.864

10.  Failure to confirm association of a polymorphism in ABCB1 with multidrug-resistant epilepsy.

Authors:  N C K Tan; S E Heron; I E Scheffer; J T Pelekanos; J M McMahon; D F Vears; J C Mulley; S F Berkovic
Journal:  Neurology       Date:  2004-09-28       Impact factor: 9.910
View more
  1 in total

1.  Methods for optimizing statistical analyses in pharmacogenomics research.

Authors:  Stephen D Turner; Dana C Crawford; Marylyn D Ritchie
Journal:  Expert Rev Clin Pharmacol       Date:  2009-09-01       Impact factor: 5.045
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.